A topical cosmetic hexapeptide (Acetyl Hexapeptide-8) marketed for the appearance of expression lines. It is a skincare ingredient, not an injectable.
Mechanism under study
Argireline mimics part of the SNAP-25 protein and is proposed to interfere with SNARE-complex formation, modestly reducing the muscle contractions associated with expression wrinkles — a topical 'Botox-like' effect, though far weaker.
Research-reported dosing
Cosmetic topical only — formulated in serums and creams, commonly around 5-10%. It is not an injectable, and no systemic dosing is established.
Not reconstituted for injection — it is a topical cosmetic, typically supplied as an aqueous solution blended into skincare formulations.
Open this mix in the calculator →Dosing figures describe how this compound appears in the research literature and research-community references. They are not a recommendation for human use.
Argireline FAQ
What is Argireline?
A topical cosmetic hexapeptide (Acetyl Hexapeptide-8) marketed for the appearance of expression lines. It is a skincare ingredient, not an injectable.
What is the half-life of Argireline?
Not applicable in the injectable sense — it is formulated for topical use.
What is the research-reported dosing for Argireline?
Cosmetic topical only — formulated in serums and creams, commonly around 5-10%. It is not an injectable, and no systemic dosing is established.
How is Argireline reconstituted?
Not reconstituted for injection — it is a topical cosmetic, typically supplied as an aqueous solution blended into skincare formulations.
Is Argireline FDA-approved?
No — Argireline is not FDA-approved and is sold for laboratory research use only.
References
Related peptides
GHK-Cu
Copper-binding tripeptide (Gly-His-Lys)
A naturally occurring copper-binding tripeptide whose plasma level declines with age. Extensively studied in skin biology for remodeling, and in topical cosmetic formulations.
Afamelanotide
Synthetic alpha-MSH (MC1R) analog
A synthetic analog of alpha-MSH, approved as Scenesse (a subcutaneous implant) for the rare light-sensitivity disorder erythropoietic protoporphyria. It is the same molecule as melanotan I.